Exam 3 - Meds Only Flashcards
Sulfonylureas - glipizide (Glucotrol); glyburide (Micronase, Diabeta, glimepride (Amaryl)
- Secretagogue: stimulates insulin secretion from beta cell.
- Constantly working - - could lead to hypoglycemia
- take with food
Meglitinides - repaglinide (Prandin), nateglinide (Starlix)
- Stimulate a rapid and short lived release of insulin from the pancreas
- Burst of insulin - - then it stops
- Take with food
Biguanide - metformin (Glucophage), metformin ER (Glumetza)
- *First Line for Type 2**
- Reduces hepatic glucose production
- Sensitizer: increases insulin sensitivity to peripheral uptake
Thiazolidineodione - pioglitazone (Actos), rosiglitazone (Avandia)
- Makes tissues more sensitive to insulin
- Sensitizer: increases insulin sensitivity to peripheral uptake
a-glucosidase inhibitor - acarbose (Precose), miglitol (Glyset)
Take with very 1st bite of every meal or don’t take at all. Food gets absorbed further down GI tract - causes cramps, gas, GI problems.
- Slows absorption of food in stomach
- Slows absorption of glucose, slows postprandial hyperglycemia.
DPP-4 Inhibitors - sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta)
- Enhances the incretin system, stimulates release of insulin from pancreatic B cells.
SGLT2 Inhibitors - Canagliflozin (Invokana), dapagliflozin (farxiga)
- Sodium-glucose transporter 2 (SGLT2) works in the kidney to reabsorb glucose, this new class of medication, SGLT2 inhibitors, blocks this action causing excess glucose to be eliminated in urine.
- At risk for UTI because of increase in glucose in urine.
Bile Acid Sequestrant (BAS) - colesevelam (Welchol)
A cholesterol lowering medication that also reduces blood glucose levels in patients with diabetes.
Dopamine Receptor Agonist - Bromocitine (Cycloset)
Increases CNS dopamine receptor activity, increases insulin sensitivity and decreases A1C by improving postprandial hepatic glucose metabolism and increasing glucose uptake.
Incretins (Injections but not insulin)
Exenatide (Byetta), Exenatide ER once-weekly (Bydureon), Liraglutide (Victoza)
Stimulates release of insulin, decrease glucagon secretion, increase satiety, decrease gastric emptying
Amylin Analog (Injections but not insulin) - Pramlintide (Symlin)
Decrease gastric emptying, decrease glucagon secretions and endogenous glucose output from the liver, increase satiety
Insulin - Lispro or Aspart
Rapid Acting
- Onset: 15 min
- Peak: 60-90 min
- Duration: 2-4 hrs
Insulin - Human Regular
mix with Human NPH
NPO/Tube feeding
- Onset: 30-60 min
- Peak: 2-3 hrs
- Duration: 3-6 hrs
Insulin - Human NPH
mix with Human Regular
Intermediate Acting
- Onset: 2-4 hrs
- Peak: 4-10 hrs
- Duration: 10-16 hrs
Insulin - Glargine
Long Acting
- Onset: 1-2 hrs
- Peak: Peakless
- Duration: 24 hrs
- Crystallizes under skin because different pH than body; slowly adjusts to the bodies pH